4 completed, 1 not yet recruiting. 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Mirabegron 50mg: new trials by email Literature Review of Mirabegron 50mg trials Research Report on Mirabegron 50mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mirabegron in Patients With Age-Related Macular Degeneration Mirabegron 50mg, Solifenacin 5mg - Dry AMD, Overactive Bladder | Not yet recruiting | University of Naples | 312 | 2026-04-01 | 2026-02-06 | |
| A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients Mirabegron 100 mg, Mirabegron 50mg, mirabegron 25 mg - Cirrhosis, Asthma | Phase 4 | Completed | Kafrelsheikh University | 78 | 2024-07-01 | 2026-04-16 |
| Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg - Healthy | Phase 1 | Completed | Dong-A ST Co., Ltd. | 37 | 2023-08-22 | 2024-01-25 |
| Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event. mirabegron 50mg - Overactive Bladder | Phase 4 | Completed | Samsung Medical Center | 434 | 2015-06-01 | 2018-02-28 |
| Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate Propranolol, Pindolol, Dantrolene - Healthy Volunteers | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 47 | 2014-02-07 | 2024-10-16 |
Urinary Bladder, Overactive (2) · Asthma (1) · Fibrosis (1)
Dong-A ST Co., Ltd. (1) · Kafrelsheikh University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Samsung Medical Center (1) · University of Naples (1)
South Korea (2) · Egypt (1) · Italy (1) · United States (1)
Aya Emad Fouda, MSc in Clinical Pharmacy (1) · Kong Y Chen, Ph.D. (1) · Kyu-Sung Lee, Ph.D (1) · Noha Mahmoud ELkhodary, Associate Professor (1)